Regeneron (REGN) Reports Updates on Phase 3 Libtayo (cemiplimab) Development Program in Advanced NSCLC

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LEN
8. USO
9. LMT
10. TLT

Go back to Regeneron (REGN) Reports Updates on Phase 3 Libtayo (cemiplimab) Development Program in Advanced NSCLC
Regeneron (NASDAQ: REGN) Delayed: 789.45 --0 (-0%)
Previous Close $789.45    52 Week High $592.36 
Open $789.45    52 Week Low $325.35 
Day High $789.45    P/E 207.20 
Day Low $789.45    EPS $3.81 
Volume 203